Morning Market Gainers

(NASDAQ:

) shares jumped 160.36 percent to $2.89 following the announcement of a software licensing agreement with

(NYSE:

).

(NASDAQ:

) gained 25.43 percent to $0.439 as the company said it no longer has a $5 million payment due on Series I stock.

(NASDAQ:

) shares gained 19.57 percent to $8.25. Terraform Global is pulling out of deal to acquire shares of Renovia Energia, according to Reuters. David Tepper's Appaloosa issued a letter to TerraForm Power Directors. Analysts at Oppenheimer upgraded TerraForm Power from Perform to Outperform.

(NYSE:

) shares rose 19.55 percent to $17.98 after the company reported better-than-expected results for its fiscal first quarter and issued a strong outlook. The company's board also announced a $100 million share buyback program.

(NASDAQ:

) shares climbed 18.18 percent to $19.18 after

(NYSE:

) announced plans to acquire HF Financial Corp in a transaction valued at $19.70 per share.

(NASDAQ:

) shares rose 13.91 percent to $1.51 after the company reported a license agreement with Novo Nordisk for XMetA program in diabetes.

(NASDAQ:

) shares surged 14.08 percent to $2.35 after jumping 19.08 percent on Monday.

(NYSE:

) rose 11.86 percent to $12.54 after the company reported a new contract with Eastman Chemical through 2019

(NASDAQ:

) shares gained 9 percent to $53.80. Mattress Firm agreed to acquire HMK Mattress Holdings LLC, the holding company of Sleepy's and related entities, for $780 million. The company reported preliminary Q3 adjusted earnings of $0.80 to $0.82 per share, and sales growth of 50.7 percent.

(NASDAQ:

) shares gained 8.79 percent to $2.60 after surging 11.16 percent on Monday. Eisai and Arena Pharmaceuticals reported the completion of enrollment in BELVIQ® (lorcaserin HCI) CAMELLIA-TIMI 61 study.

(NYSE:

) rose 3.15 percent to $2.95 after announcing positive topline results from first Phase 2A clinical trial of SYN-004 for the prevention of C. difficile infection.